| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/16/1993 | EP0546134A1 AMPLIFIER AND SILENCER SEQUENCES ISOLATED FROM THE GPIIb PROMOTER |
| 06/16/1993 | EP0546127A1 Biosynthetic cerebrospinal fluid control and method of use. |
| 06/16/1993 | EP0546126A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome |
| 06/16/1993 | EP0546125A1 Osteogenic factor |
| 06/16/1993 | EP0546124A1 Multidomain hematopoiesis stimulators |
| 06/16/1993 | EP0546119A1 Cell density signal molecule isolated from embryonic tendon cells |
| 06/16/1993 | EP0546118A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 06/16/1993 | EP0546115A1 Peptides containing amino-polyols as transition-state mimics |
| 06/16/1993 | EP0546110A1 New insulin-like growth factor binding protein igfbp-5 |
| 06/16/1993 | EP0546108A1 Pro-drugs for cck antagonists |
| 06/16/1993 | EP0546101A1 METHOD OF INTERFERING WITH FORMATION OF $g(a)-ANTICHYMOTRYPSIN-$g(b)-PROTEIN COMPLEX AND SYNTHETIC PEPTIDES FOR USE THEREIN |
| 06/16/1993 | EP0546096A1 Macrophage activating factor from vitamin d binding protein |
| 06/16/1993 | EP0546091A1 Homologous recombination in mammalian cells |
| 06/16/1993 | EP0546084A1 PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID $g(b)-PROTEIN PRECURSOR |
| 06/16/1993 | EP0546081A1 New insulin-like growth factor binding protein (igfbp-4) |
| 06/16/1993 | EP0546077A1 Cd18 peptide medicaments for the treatment of disease |
| 06/16/1993 | EP0546074A1 Genetic material encoding igfbp-5 |
| 06/16/1993 | EP0546068A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 06/16/1993 | EP0546053A1 Genetic material encoding igfbp-4 |
| 06/16/1993 | EP0546031A1 Enterovirus peptides |
| 06/16/1993 | EP0546022A1 High viscosity bacteria, bacterial compositions, and methods |
| 06/16/1993 | EP0546016A1 Dna, dna constructs, cells and plants derived therefrom |
| 06/16/1993 | EP0546013A1 Glucagon analogs with asp-9 replacements or deletions |
| 06/16/1993 | EP0545946A1 Growth-promoting agent |
| 06/16/1993 | EP0538412A4 A cdna encoding the rat d 1? dopamine receptor linked to adenylyl cyclase activation and expression product |
| 06/16/1993 | EP0406259B1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
| 06/16/1993 | EP0391974B1 Process for the purification of vitamin k-dependent blood clotting factors |
| 06/16/1993 | EP0308500B1 Human somatomedin carrier protein subunits and process for producing them |
| 06/16/1993 | EP0192741B1 $i(BACILLUS THURINGIENSIS) CRYSTAL PROTEIN GENE TOXIN SEGMENT |
| 06/16/1993 | CN1073264A Therapeutic and diagnostic methods based on tissue-specific NT-3 expression and receptor binding |
| 06/16/1993 | CN1073208A Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 06/16/1993 | CN1073180A Producing technology for pineapple seed agglutinin |
| 06/16/1993 | CN1021257C Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 06/15/1993 | US5220013 Use of materials related to amyloid protein deposits |
| 06/15/1993 | US5220006 Identification of a suppressor of atherogenic apolipoprotein |
| 06/15/1993 | US5219999 Immunoglobulin g and process for the production thereof |
| 06/15/1993 | US5219998 Yeast-derived epidermal growth factor |
| 06/15/1993 | US5219996 Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules |
| 06/15/1993 | US5219995 Activating Factor II to Factor IIa using Factor Va and Factor Xa, wherein Factors II, Va, and Xa are all derived from a single impure protein fraction |
| 06/15/1993 | US5219994 Anticoagulant glycoprotein |
| 06/15/1993 | US5219993 Method of recovering purified epi protein from a solution especially a fermentation solution |
| 06/15/1993 | US5219991 Macrophage stimulating protein |
| 06/15/1993 | US5219990 Papillomavirus e2 trans-activation repressors |
| 06/15/1993 | US5219989 Second functional site binds solid support matrix so as to allow first functional site to be immobilized and still remain accessible to interact with cap structure of RNA |
| 06/15/1993 | US5219987 Sequential polypeptides endowed with immunological activity |
| 06/15/1993 | US5219837 Method of stimulating myelination of cells |
| 06/15/1993 | US5219759 Recombinant DNA encoding PDGF A-chain polypeptide and expression vectors |
| 06/15/1993 | US5219749 Process for isolating and preparing purified chitin deacetylase |
| 06/15/1993 | US5219748 Recombinant human and rat protein kinase c polypetides |
| 06/15/1993 | US5219739 Wound healing agents |
| 06/15/1993 | US5219732 Antibody-mediated cofactor-driven reactions |
| 06/15/1993 | US5219725 Monoclonal antibodies to feline-t-lymphotropic lentivirus |
| 06/15/1993 | US5219579 Culture product of tumor tissue cells; cancer diagnosis, screening |
| 06/15/1993 | US5219577 Biologically active composition having a nanocrystalline core |
| 06/15/1993 | US5219566 Immunoprophylactic polypeptides for schistosomiasis |
| 06/15/1993 | CA1319101C Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
| 06/13/1993 | CA2085142A1 Stabilized pharmaceutical composition of non glycosyled recombinant human il2 in reduced form and preparation process therefore |
| 06/12/1993 | CA2084180A1 Expression of specific immunogens using viral antigens |
| 06/11/1993 | CA2084834A1 Proteins for inhibiting adhesion of platelets to collagen |
| 06/10/1993 | WO1993011257A2 Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path |
| 06/10/1993 | WO1993011253A1 Cell-free ciliary neurotrophic factor/receptor complex |
| 06/10/1993 | WO1993011251A1 Recombinant viruses comprising artificial proteolytic cleavage site |
| 06/10/1993 | WO1993011250A1 Bicistronic viruses |
| 06/10/1993 | WO1993011248A1 Production of proteins using 7b2 protein |
| 06/10/1993 | WO1993011247A1 Prohormone convertase transformed cells |
| 06/10/1993 | WO1993011244A1 Cyclic di-guanylate metabolic enzymes |
| 06/10/1993 | WO1993011241A1 Nucleotide sequences coding an endopolygalacturonase inhibitor |
| 06/10/1993 | WO1993011240A1 Method for refolding igf-i to active conformation |
| 06/10/1993 | WO1993011239A1 New thrombin-inhibiting proteins from terrestrial leeches |
| 06/10/1993 | WO1993011237A1 Cdr grafted humanised chimeric t-cell antibodies |
| 06/10/1993 | WO1993011236A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 06/10/1993 | WO1993011235A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 06/10/1993 | WO1993011234A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
| 06/10/1993 | WO1993011233A1 Dna fragment which codes for tumor cell proliferation inhibiting factor |
| 06/10/1993 | WO1993011232A1 Ifn-gamma antagonist cytokine |
| 06/10/1993 | WO1993011231A1 Tools for the diagnosis and treatment of alzheimer's disease |
| 06/10/1993 | WO1993011230A1 Modified mammalian stem cell blocking viral replication |
| 06/10/1993 | WO1993011229A1 Novel polypeptides for promoting cell attachment |
| 06/10/1993 | WO1993011223A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
| 06/10/1993 | WO1993011222A1 Lipocortin-1 receptor protein and its uses |
| 06/10/1993 | WO1993011219A1 Novel adherent and invasive mycoplasma |
| 06/10/1993 | WO1993011162A1 Bispecific antibody heterodimers |
| 06/10/1993 | WO1993011159A1 Human interleukin-8 analogs |
| 06/10/1993 | WO1993011158A2 Non-a, non-b peptides |
| 06/10/1993 | WO1993011157A1 MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX) |
| 06/10/1993 | WO1993011156A1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 06/10/1993 | WO1993011155A1 Fragments of prion proteins |
| 06/10/1993 | WO1993011154A1 Inhibitors of the conversion of big endothelin to endothelin |
| 06/10/1993 | WO1993011153A1 Peptides and antibodies for treatment of rheumatoid arthritis |
| 06/10/1993 | WO1993011152A1 New peptide derivatives |
| 06/10/1993 | WO1993011151A1 ALBOAGGREGINS: PLATELET AGONISTS WHICH BIND TO PLATELET MEMBRANE GLYCOPROTEIN Ib |
| 06/10/1993 | WO1993011149A1 Methods of detecting a genetic predisposition for osteoporosis |
| 06/10/1993 | WO1993011147A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/10/1993 | WO1993010816A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
| 06/10/1993 | WO1993010814A1 Anti-cancer immunotherapeutic vector constructs |
| 06/10/1993 | WO1993010813A1 Nucleotide and amino acid sequence of pemphigus vulgaris antigen and methods of use |
| 06/10/1993 | WO1993010812A1 Use of protease nexin-i as an antiinflammatory |
| 06/10/1993 | WO1993010811A1 Proteolytic mixture containing escharase and method of isolating same |
| 06/10/1993 | WO1993010807A1 Hemoregulatory peptides |